Cumulus Oncology



Nicola Broughton joins Cumulus Oncology as non-executive director

Edinburgh-based Cumulus Oncology has appointed Nicola Broughton as a non-executive director as Europe’s first oncology drug discovery accelerator continues in scale-up mode and targets its next investment round.

Published 22 July 2021

Greenshoots: Cumulus Oncology eyes further growth as US office is set to open this year

Edinburgh-headquartered Cumulus Oncology, Europe’s first oncology drug discovery accelerator, is eyeing global alliances, VC partnerships and a US office opening in 2021, with CEO and co-founder Clare Wareing seeing additional growth opportunities in Europe and Asia.

Published 17 February 2021

Eos Advisory backs Europe’s first oncology drug discovery accelerator Cumulus

St Andrews-based investment firm Eos Advisory has backed Europe’s first oncology drug discovery accelerator, Cumulus Oncology, leading a £1.7 million investment round.

Published 13 July 2020